Stockreport

AzurRx BioPharma Announces Positive Results from Independent Data Monitoring Committee Review of Safety Data from Part 1 of RESERVOIR Phase 2 Clinical Trial of Niclosamide for the Treatmen...

AzurRx BioPharma, Inc.  (AZRX) 
Last azurrx biopharma, inc. earnings: 11/14 04:31 pm Check Earnings Report
PDF Review of Interim Safety Data Concluded with Favorable Recommendation to Continue RESERVOIR Trial as Planned Part 2 of RESERVOIR Trial to Enroll Up to 150 Patients to E [Read more]